R74.01 Code facturable et spécifique Elevation of levels of liver transaminase levels

ICD-10-CM R74.01 identifies “Elevation of levels of liver transaminase levels” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapitre 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Instructions du code

Inclusion terms2
  • Elevation of levels of alanine transaminase (ALT)
  • Elevation of levels of aspartate transaminase (AST)

Instructions des niveaux supérieurs

Chapitres 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 24
  • abnormal findings on antenatal screening of mother (O28.-)
  • certain conditions originating in the perinatal period (P04-P96)
  • signs and symptoms classified in the body system chapters
  • signs and symptoms of breast (N63, N64.5)
Note9
  • This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
  • Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
  • The conditions and signs or symptoms included in categories R00-R94 consist of:
  • (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
  • (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
  • (c) provisional diagnosis in a patient who failed to return for further investigation or care;
  • (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
  • (e) cases in which a more precise diagnosis was not available for any other reason;
  • (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R70-R79 · Abnormal findings on examination of blood, without diagnosis (R70-R79)

Excludes 27
  • abnormal findings on antenatal screening of mother (O28.-)
  • abnormalities of lipids (E78.-)
  • abnormalities of platelets and thrombocytes (D69.-)
  • abnormalities of white blood cells classified elsewhere (D70-D72)
  • coagulation hemorrhagic disorders (D65-D68)
  • diagnostic abnormal findings classified elsewhere - see Alphabetical Index
  • hemorrhagic and hematological disorders of newborn (P50-P61)
Références de l’index officiel

Références de l’index officiel (12)

Elevated, elevation (8)
Findings, abnormal, inconclusive, without diagnosis (3)
Transaminasemia (1)

Historique officiel de conversion

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Dates de validité 2020-10-01

Attribution précédente: R74.0

Historique

Historique du code

Dernière modification enregistrée · FY2021

ModifiéInchangé
FY2021

En vigueur dès le

  • Ajouté

Elevation of levels of liver transaminase levels

Code de diagnostic facturable

CDC/NCHS · FY2021

Toutes les éditions (13)

Toutes les éditionsEn vigueur dès leHistorique du code
FY20212020-10-01Ajouté
FY2021 · 01-012021-01-01Aucun changement tabulaire
FY20222021-10-01Aucun changement tabulaire
FY2022 · 04-012022-04-01Aucun changement tabulaire
FY20232022-10-01Aucun changement tabulaire
FY2023 · 04-012023-04-01Aucun changement tabulaire
FY20242023-10-01Aucun changement tabulaire
FY2024 · 04-012024-04-01Aucun changement tabulaire
FY20252024-10-01Aucun changement tabulaire
FY2025 · 04-012025-04-01Aucun changement tabulaire
FY20262025-10-01Aucun changement tabulaire
FY2026 · April2026-04-01Aucun changement tabulaire
FY20272026-10-01Aucun changement tabulaire

Cette entrée est un code complet dans l’édition sélectionnée. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.